About this trial
Masquelet's induced membrane technique is a two-stage reconstructive surgery for severe bone fractures commonly used by military orthopedists. The particularity of this technique relies on the synthesis of a biological membrane induced by the transient implantation of a surgical cement (= 1st stage surgery). The presence of the induced membrane in the reconstruction space defines a microenvironment or "biological chamber" favourable to osteogenesis, positively influencing the repair of the lesion after implantation of an autologous bone graft (= 2nd stage of surgery).
In view of the excellent clinical results obtained with this procedure, the Masquelet technique has gradually become a reference treatment in the field of orthopedic and trauma surgery.
However, orthopedic surgeons sometimes observe failures in bone consolidation. To our knowledge, the role played by induced membrane in these therapeutic failures has never been studied.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Patient with traumatic bone loss
Patient eligible for the induced membrane technique
Disqualifiers
Patients with post-tumor bone loss
Patients who are immunocompromised or under immunosuppressive treatment
Patients with chronic inflammatory disease (diabetes, inflammatory bowel disease)
Patients with collagenosis
Trial design
Treatments tested in this trial
- Blood sample collection
- Other biological sample collection
- Surgical waste collection
- Radiological examination and functional exploration